GLS and cancer: Given that glutamine metabolism is at the root of human cancers and that GLS expression in cancer cells can discern their response to GLS-inhibiting drugs, an increasing number of studies have investigated the metabolic pathways in CSCs and the possibility of using them as a new target for anticancer drugs.